CEACAM5 and metabolic dysfunction-associated steatohepatitis: Cancer antigen 19-9 was elevated in NASH-HCC, recording 43.2 ± 4.3 U/mL, which is higher than the accepted upper limit of 37 U/mL, while carcinoembryonic antigen was within the normal range in both groups.